15013567|t|Evaluation of HFE (hemochromatosis) mutations as genetic modifiers in sporadic AD and MCI.
15013567|a|BACKGROUND: Pathological brain iron deposition has been implicated as a source of neurotoxic reactive oxygen species in Alzheimer disease (AD). Recent reports suggest that heterozygosity for the two common hfe mutations responsible for hereditary hemochromatosis (HH) may be a risk factor for AD, possibly by accelerating brain iron accumulation. METHODS: To test this hypothesis, we genotyped 213 sporadic AD, 106 MCI, and 63 normal elderly control (NEC) individuals for the H63D and C282Y hfe mutations by polymerase chain reaction (PCR)/restriction fragment length polymorphism (RFLP) analysis. We determined the relationship of these mutations to the demographic, clinical, and neuropsychological features of AD and MCI, and evaluated whether an interaction existed between hfe and apolipoprotein E (apoE) status in these patients. RESULTS: We observed no significant impact of H63D or C282Y heterozygosity on age at AD symptoms onset or diagnosis, age at onset of cognitive symptoms (AD and MCI combined), rates of MCI-to-AD conversion or specific neuropsychological deficits. No interactions between hfe zygosity and apoE status were discerned. Patients homozygous for H63D exhibited trends towards accelerated MCI-to-AD conversion rates and a subset of younger individuals (aged 55-75) exhibited earlier onset of cognitive symptoms relative to wild-type hfe and H63D heterozygotes. CONCLUSIONS: Contrary to earlier reports, the results of the present study do not implicate the common hfe mutations as genetic modifiers of sporadic AD and MCI. Trends towards accelerated cognitive dysfunction in H63D homozygotes warrant further study.
15013567	14	17	HFE	Gene	3077
15013567	19	34	hemochromatosis	Gene	3077
15013567	79	81	AD	Disease	MESH:D000544
15013567	86	89	MCI	Disease	
15013567	122	126	iron	Chemical	MESH:D007501
15013567	173	183	neurotoxic	Disease	MESH:D020258
15013567	184	207	reactive oxygen species	Chemical	MESH:D017382
15013567	211	228	Alzheimer disease	Disease	MESH:D000544
15013567	230	232	AD	Disease	MESH:D000544
15013567	297	300	hfe	Gene	3077
15013567	327	353	hereditary hemochromatosis	Disease	MESH:D006432
15013567	355	357	HH	Disease	MESH:D006432
15013567	384	386	AD	Disease	MESH:D000544
15013567	419	436	iron accumulation	Chemical	-
15013567	498	500	AD	Disease	MESH:D000544
15013567	506	509	MCI	Disease	
15013567	567	571	H63D	ProteinMutation	tmVar:p|SUB|H|63|D;HGVS:p.H63D;VariantGroup:1;CorrespondingGene:3077;RS#:1799945;CorrespondingSpecies:9606;CA#:113797
15013567	576	581	C282Y	ProteinMutation	tmVar:p|SUB|C|282|Y;HGVS:p.C282Y;VariantGroup:0;CorrespondingGene:3077;RS#:1800562;CorrespondingSpecies:9606;CA#:113795
15013567	582	585	hfe	Gene	3077
15013567	804	806	AD	Disease	MESH:D000544
15013567	811	814	MCI	Disease	
15013567	869	872	hfe	Gene	3077
15013567	877	893	apolipoprotein E	Gene	348
15013567	895	899	apoE	Gene	348
15013567	917	925	patients	Species	9606
15013567	973	977	H63D	ProteinMutation	tmVar:p|SUB|H|63|D;HGVS:p.H63D;VariantGroup:1;CorrespondingGene:3077;RS#:1799945;CorrespondingSpecies:9606;CA#:113797
15013567	981	986	C282Y	ProteinMutation	tmVar:p|SUB|C|282|Y;HGVS:p.C282Y;VariantGroup:0;CorrespondingGene:3077;RS#:1800562;CorrespondingSpecies:9606;CA#:113795
15013567	1012	1014	AD	Disease	MESH:D000544
15013567	1060	1078	cognitive symptoms	Disease	MESH:D019954
15013567	1080	1082	AD	Disease	MESH:D000544
15013567	1087	1090	MCI	Disease	
15013567	1111	1114	MCI	Disease	
15013567	1118	1120	AD	Disease	MESH:D000544
15013567	1144	1171	neuropsychological deficits	Disease	MESH:D009461
15013567	1197	1200	hfe	Gene	3077
15013567	1214	1218	apoE	Gene	348
15013567	1242	1250	Patients	Species	9606
15013567	1266	1270	H63D	ProteinMutation	tmVar:p|SUB|H|63|D;HGVS:p.H63D;VariantGroup:1;CorrespondingGene:3077;RS#:1799945;CorrespondingSpecies:9606;CA#:113797
15013567	1308	1311	MCI	Disease	
15013567	1315	1317	AD	Disease	MESH:D000544
15013567	1411	1429	cognitive symptoms	Disease	MESH:D019954
15013567	1452	1455	hfe	Gene	3077
15013567	1460	1464	H63D	ProteinMutation	tmVar:p|SUB|H|63|D;HGVS:p.H63D;VariantGroup:1;CorrespondingGene:3077;RS#:1799945;CorrespondingSpecies:9606;CA#:113797
15013567	1583	1586	hfe	Gene	3077
15013567	1630	1632	AD	Disease	MESH:D000544
15013567	1637	1640	MCI	Disease	
15013567	1669	1690	cognitive dysfunction	Disease	MESH:D003072
15013567	1694	1698	H63D	ProteinMutation	tmVar:p|SUB|H|63|D;HGVS:p.H63D;VariantGroup:1;CorrespondingGene:3077;RS#:1799945;CorrespondingSpecies:9606;CA#:113797
15013567	Positive_Correlation	MESH:D019954	RS#:1799945;HGVS:p.H63D;CorrespondingGene:3077
15013567	Positive_Correlation	MESH:D006432	RS#:1799945;HGVS:p.H63D;CorrespondingGene:3077
15013567	Positive_Correlation	MESH:D006432	RS#:1800562;HGVS:p.C282Y;CorrespondingGene:3077
15013567	Positive_Correlation	MESH:D003072	RS#:1799945;HGVS:p.H63D;CorrespondingGene:3077
15013567	Association	MESH:D007501	MESH:D000544
15013567	Association	MESH:D000544	3077
15013567	Association	MESH:D017382	MESH:D000544
15013567	Positive_Correlation	MESH:D007501	MESH:D017382
15013567	Association	MESH:D006432	3077
15013567	Positive_Correlation	MESH:D007501	MESH:D020258
15013567	Association	MESH:D019954	3077
15013567	Association	MESH:D006432	3077
15013567	Association	MESH:D003072	3077

